Abstract
Preeclampsia remains a leading cause of maternal and neonatal morbidity and mortality. The pathophysiology of preeclampsia remains poorly understood with various pathological mechanisms being implicated including the renin angiotensin system (RAAS), angiogenic pathways and various components of the immune system. Recently a pathogenic autoimmune factor has been identified in the form of auto-agonistic angiotensin II type 1 receptor antibodies (AT1-AA). AT1-AA have been studied in vitro and in vivo in various human and animal models and these data have provided compelling evidence for their role in preeclampsia. This review summarises the current literature surrounding the role of AT1-AA in preeclampsia and draws links between this relatively novel antibody to well-established pathological mechanisms including the immune system, the RAAS, angiogenic pathways and placental ischaemia.
| Original language | English |
|---|---|
| Pages (from-to) | 369-382 |
| Number of pages | 14 |
| Journal | Hypertension in Pregnancy |
| Volume | 34 |
| Issue number | 3 |
| DOIs | |
| Publication status | Published - 2015 |
Keywords
- Angiotensin II
- placenta
- preeclampsia